⌘K

Login Start Free

Home/Filings/4/0000950170-24-072095

4//SEC Filing

Ebeling Thomas 4

Accession 0000950170-24-072095

CIK 0001789972other

View on SEC.gov Company Profile

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 6:00 PM ET

Size

6.7 KB

Accession

0000950170-24-072095

Insider Transaction Report

Form 4

Period: 2024-06-10

Cullinan Therapeutics, Inc.CGEM

Director

Transactions

Exercise/Conversion
Common Stock
2024-06-10$13.00/sh+18,450$239,850→ 186,653 total
Exercise/Conversion
Stock Option (Right to Buy)
2024-06-10−18,450→ 0 total
Exercise: $13.00From: 2024-06-08Exp: 2033-06-07→ Common Stock (18,450 underlying)

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Cullinan Therapeutics, Inc.

CIK 0001789972

Entity typeother

Related Parties

1

filerCIK 0001297759

Filing Metadata

Form type: 4
Filed: Jun 10, 8:00 PM ET
Accepted: Jun 11, 6:00 PM ET
Size: 6.7 KB

View on SEC.gov